Nina Tagayon's Contact Details

Nina Tagayon's Company Details

Imperial College London Diabetes Centre

, , • 500 - 999 Employees
Other

Imperial College London Diabetes Centre is a one-stop, state-of-the-art, out-patient facility specialising in diabetes treatment, research, training.The Centre opened in Abu Dhabi in 2006, in partnership with Imperial College London, as the first healthcare facility established by Mubadala Development Company. Imperial College London Diabetes Centre has developed a tailored, multi-disciplinary, holistic approach to the treatment of diabetes, endocrinology and its related complications so that patients get the full spectrum of care they need, all in one place.TreatmentImperial College London Diabetes Centre has developed a specific approach to diabetes care, based on the particular needs of Abu Dhabi, UAE and the wider region, and offers the highest level of specialised patient care from first diagnosis to the management of diabetes and all associated complications.Public HealthUnder the patronage of Her Highness Sheikha Fatima bint Mubarak, Imperial College London Diabetes Centre has developed a community resource, Diabetes.Knowledge.Action, now the longest running public health awareness campaign in the country. The campaign promotes public health lifestyle activities and events around balanced diet, maintaining healthy body weight and engaging in daily exercise routines. Major activations include the annual walkathon coinciding with World Diabetes Day in November.Training and EducationEducation is one of the four key pillars in the Centre's approach to tackle diabetes. The Centre organises specialist conferences accredited for Continuing Medical Education (CME) credits for healthcare professionals, as well as weekly in-house seminars for resident doctors.ResearchImperial College London Diabetes Centre encompasses epidemiological, basic, clinical and genetic research focusing on diabetes in the UAE, as well as general surveys amongst the public who take part in our campaign activities. The research is world-class, particularly directed to explaining the high prevalence of diabetes and obesity in the country, aiming to find mechanisms to slow down and reverse the trend.